Literature DB >> 19446372

No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.

Sara Rollinson1, Jonathan D Rohrer, Julie van der Zee, Kristel Sleegers, Simon Mead, Sebastiaan Engelborghs, John Collinge, Peter P De Deyn, David M A Mann, Christine Van Broeckhoven, Stuart M Pickering-Brown.   

Abstract

Frontotemporal lobar degeneration (FTLD) is a highly familial neurodegenerative disease. It has been claimed that homozygosity of the SNP rs5848 located in the 3'UTR of progranulin increases risk for FTLD. We have attempted to replicate the association of rs5848 in three independent FTLD cohorts. No association of rs5848 with FTLD was observed in any individual cohort nor was any observed when the data was combined. These data argue that rs5848 is not a risk factor for FTLD.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446372     DOI: 10.1016/j.neurobiolaging.2009.04.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 2.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 3.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

4.  Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.

Authors:  Corey T McMillan; Jon B Toledo; Brian B Avants; Philip A Cook; Elisabeth M Wood; Eunran Suh; David J Irwin; John Powers; Christopher Olm; Lauren Elman; Leo McCluskey; Gerard D Schellenberg; Virginia M-Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman
Journal:  Neurobiol Aging       Date:  2013-12-02       Impact factor: 4.673

5.  rs5848 polymorphism and serum progranulin level.

Authors:  Ging-Yuek R Hsiung; Alice Fok; Howard H Feldman; Rosa Rademakers; Ian R A Mackenzie
Journal:  J Neurol Sci       Date:  2010-11-02       Impact factor: 3.181

Review 6.  Human genetics as a tool to identify progranulin regulators.

Authors:  Alexandra M Nicholson; NiCole A Finch; Rosa Rademakers
Journal:  J Mol Neurosci       Date:  2011-05-28       Impact factor: 3.444

7.  Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically.

Authors:  Winnie C Pao; Dennis W Dickson; Julia E Crook; NiCole A Finch; Rosa Rademakers; Neill R Graff-Radford
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

8.  MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia.

Authors:  Jian Jiao; Lauren D Herl; Robert V Farese; Fen-Biao Gao
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

Review 9.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

10.  Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.

Authors:  Alice S Chen-Plotkin; Jiping Xiao; Felix Geser; Maria Martinez-Lage; Murray Grossman; Travis Unger; Elisabeth M Wood; Vivianna M Van Deerlin; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2009-08-02       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.